Growth Metrics

Acadia Pharmaceuticals (ACAD) Interest Expenses (2018 - 2019)

Acadia Pharmaceuticals (ACAD) has 2 years of Interest Expenses data on record, last reported at $12000.0 in Q2 2019.

  • For Q2 2019, Interest Expenses changed N/A year-over-year to $12000.0; the TTM value through Mar 2020 reached $12000.0, down 99.34%, while the annual FY2018 figure was $1.8 million, N/A changed from the prior year.
  • Interest Expenses reached $12000.0 in Q2 2019 per ACAD's latest filing, down from $229000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $1.7 million in Q3 2018 and bottomed at -$127000.0 in Q4 2018.